Handok, Bayer Korea to join forces in contrast agent

Handok Pharmaceutical and Bayer Korea said on December 15 they have agreed to join hands to co-market iopromide Inj.

Both companies will co-promote iopromide contrast agent under the different brandnames - Ulltravist and Ultracon.

Iopromide is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent indicated for intra-arterial...